Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 15 December

Sophia Mavridis
December 15, 2021

Morning Bell 14 December

Paulina Peters
December 14, 2021

Morning Bell 13 December

Sophia Mavridis
December 13, 2021

Weekly Wrap 10 December

Sophia Mavridis
December 10, 2021

Morning Bell 9 December

Paulina Peters
December 9, 2021

Morning Bell 8 December

Sophia Mavridis
December 8, 2021

Morning Bell 7 December

Paulina Peters
December 7, 2021

Morning Bell 6 December

Sophia Mavridis
December 6, 2021

Weekly Wrap 3 December

Sophia Mavridis
December 3, 2021

Morning Bell 2 December

Paulina Peters
December 2, 2021

Morning Bell 1 December

Sophia Mavridis
December 1, 2021

Morning Bell 30 November

Paulina Peters
November 30, 2021